Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 30.57 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2026-02-13
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-12-31 was 1.64K shares, a 2.44% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-09-30 was 15.15K shares, a 650.84% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-06-30 was 11.50K shares.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-03-31 was 2.28K shares, a 159.16% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2024 was 30.57K shares, a 579.83% increase from fiscal 2023.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 4.50K shares, a 411.60% increase from fiscal 2022.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 879.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|---|---|---|
| 2024-12-31 | 1.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 16.79K shares derived: sum of 2 quarters · filed 2026-02-13 | 28.29K shares derived: sum of 3 quarters · filed 2026-02-13 | 30.57K shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 15.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 26.66K shares derived: sum of 2 quarters · filed 2024-11-04 | 28.93K shares 10-Q · filed 2024-11-04 | 30.53K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | 11.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 13.78K shares 10-Q · filed 2024-08-06 | 15.38K shares derived: sum of 3 quarters · filed 2026-02-13 | 17.40K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | 2.28K shares 10-Q · filed 2024-05-07 | 3.88K shares derived: sum of 2 quarters · filed 2026-02-13 | 5.90K shares derived: sum of 3 quarters · filed 2026-02-13 | 5.90K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | 1.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 3.62K shares derived: sum of 2 quarters · filed 2026-02-13 | 3.62K shares derived: sum of 3 quarters · filed 2026-02-13 | 4.50K shares 10-K · filed 2026-02-13 |
| 2023-09-30 | 2.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 2.02K shares derived: sum of 2 quarters · filed 2023-11-07 | 2.90K shares 10-Q · filed 2023-11-07 | 2.90K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 879.00 shares 10-Q · filed 2023-08-01 | 879.00 shares derived: sum of 3 quarters · filed 2025-02-10 | 879.00 shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | 879.00 shares 10-Q · filed 2023-05-02 | 879.00 shares derived: sum of 2 quarters · filed 2025-02-10 | 879.00 shares derived: sum of 3 quarters · filed 2025-02-10 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-10 | 879.00 shares 10-K · filed 2025-02-10 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 879.00 shares 10-Q · filed 2022-11-01 | ||
| 2022-06-30 | 879.00 shares 10-Q · filed 2022-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |